0.00% -0.0001

Dopo l'orario di chiusura: 2.59

Neuraxis Inc (NRXS)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Neuraxis Inc Borsa (NRXS) Ultime notizie

Neuraxis Inc (NRXS)

Neuraxis Inc Borsa (NRXS) Ultime notizie

Southside Bancshares, Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange - The Manila Times

NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market - GlobeNewswire

IRIDEX (NASDAQ:IRIX) versus NeurAxis (NASDAQ:NRXS) Financial Survey - Defense World

NeurAxis Announces Capital Blue Cross Medical Policy Coverage for PENFS, effective October 1st 2024 - The Manila Times

NeurAxis Announces New CPT® Category I Code for Percutaneous Electrical Nerve Field Stimulation - GlobeNewswire

Neuraxis adjusts equity agreement, secures additional funding - Investing.com India

Creatd (NASDAQ:VOCL) Stock Price Down 4.4% – Should You Sell? - Defense World

Technip Energies (OTCMKTS:THNPY) Trading Up 0.7% – Here’s What Happened - Defense World

Vestas Wind Systems A/S (OTCMKTS:VWSYF) Shares Up 1.2% – Here’s What Happened - Defense World

Zacks Initiates Coverage of NeurAxis With Neutral Recommendation - Yahoo Finance

The Zacks Analyst Blog Highlights Costco Wholesale, Alibaba, GE Aerospace, Applied Energetics and NeurAxis - Yahoo Finance

Top Analyst Reports for Costco Wholesale, Alibaba & GE Aerospace - Yahoo Finance

NeurAxis (NASDAQ:NRXS) Trading Up 6% - Defense World

NeurAxis to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024 - GlobeNewswire

Neuraxis issues shares in equity financing By Investing.com - Investing.com Australia

Neuraxis issues shares in equity financing - Investing.com

Fishers startup prepares to go public - Greenfield Daily Reporter

NeurAxis (NASDAQ:NRXS) Stock Price Down 2.2% - Defense World

NeurAxis Announces Geisinger Health Plan Medical Policy Coverage for PENFS, Effective September 15 2024 - GlobeNewswire

Vagus Nerve Stimulators Market Projected to Witness Huge Growth - openPR

Neuraxis shareholders approve key proposals at annual meeting - Investing.com

NeurAxis Announces BCBS of Vermont Medical Policy Coverage for PENFS, effective October 1st 2024 - GlobeNewswire

NeurAxis revenue down 5.3% to USD 611.5K in Q2 2024 - Medical Buyer

NeurAxis, Inc. (NRXS) Q2 2024 Earnings Call Transcript - Seeking Alpha

Contrasting Sonova (OTCMKTS:SONVY) & NeurAxis (NASDAQ:NRXS) - Defense World

NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024 - MSN

NeurAxis Reports Second Quarter 2024 Financial Results - GlobeNewswire

NeurAxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Vagus Nerve Stimulators Market Is Booming Worldwide 2024-2031 | - openPR

NeurAxis to Host Second Quarter 2024 Results and Business Update Call on Friday, August 9, 2024 - GlobeNewswire

NeurAxis Gains $3 Million In Financing - MPO-mag

Head to Head Comparison: NeurAxis (NASDAQ:NRXS) vs. Positron (OTCMKTS:POSC) - Defense World

Vagus Nerve Stimulators Market Expected to Expand at a Steady - openPR

NeurAxis to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 - Marketscreener.com

ZUU Co. Ltd. executives purchase Pono Capital two shares worth $390 By Investing.com - Investing.com India

Neuraxis issues stock awards to non-employee directors - Investing.com

Blackstone director Baratta sells over $14 million in company stock By Investing.com - Investing.com UK

Head to Head Survey: NeurAxis (NASDAQ:NRXS) versus Electromed (NYSE:ELMD) - Defense World

NeurAxis (NASDAQ:NRXS) and Cutera (NASDAQ:CUTR) Head-To-Head Analysis - Defense World

NRXSNeurAxis, Inc. Latest Stock News & Market Updates - StockTitan

NeurAxis (NASDAQ:NRXS) Stock Price Down 3.3% - Defense World

Nexalin Technology (NASDAQ:NXL) & NeurAxis (NASDAQ:NRXS) Financial Review - Defense World

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with ... - GlobeNewswire

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - GlobeNewswire Inc.

NeurAxis Announces New Submission to the FDA for the Expansion of its IB-Stim Label; Provides Compliance with NYSE Guidelines on Audit Disclosure - Yahoo Finance

Outset Medical (NASDAQ:OM) & NeurAxis (NASDAQ:NRXS) Head-To-Head Analysis - Defense World

Vagus Nerve Stimulators Market to Surpass US$ 1,158.7 Mn by 2031 with CAGR 9.7% - WhaTech

NeurAxis Reports First Quarter 2024 Financial Results - br.ADVFN.com

Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store? - MSN

Reviewing NeurAxis (NASDAQ:NRXS) and Outset Medical (NASDAQ:OM) - Defense World

NeurAxis, Inc. (NRXS) Q1 2024 Earnings Call Transcript - Seeking Alpha

NRXS Stock Earnings: Neuraxis Reported Results for Q1 2024 - MSN

Simile a NRXS